N/A
N=33
Kinesiotaping in Lateral Epicondylitis
Lateral Epicondylitis
Bottom Line
View on ClinicalTrials.gov: NCT03074500 ↗Enrolled (actual)
33
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcome: Primary: Patient Rated Tennis Elbow Evaluation (PRTEE) — 49; 53.75; 49.25; 26.5 units on a scale — p=0.643
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Kinesiotaping (Device); Sham taping (Other); Exercise (Other)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Marmara University
- Primary completion
- Apr 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Rated Tennis Elbow Evaluation (PRTEE) |
49; 53.75; 49.25; 26.5; 50.25; 46.25 | 0.643 |
| SECONDARY The Disabilities of the Arm, Shoulder and Hand Score (QuickDash) |
50; 46.57; 46.59; 29.5; 47.72; 39.77 | 0.633 |
| SECONDARY Visual Analogue Scale (VAS) at Rest |
1.5; 1.5; 3; 0; 1.5; NA | 0.715 |
| SECONDARY Visual Analogue Scale (VAS) at Daily Activity |
6.5; 7.5; 7; 5; 7; NA | 0.103 |
| SECONDARY Visual Analogue Scale (VAS) at Night |
2.5; 2.5; 3.5; 0; 2; 1 | 0.837 |
| SECONDARY Painless Grip Strength |
14; 12; 13; 17; 13; NA | 0.897 |
| SECONDARY Grip Strength |
20; 19.5; 23.5; 22; 19.5; NA | 0.958 |
Summary
The aim of this study is to compare the effects of kinesiology taping with exercise, sham taping with exercise and exercise alone for lateral epicondylitis.
Eligibility Criteria
Inclusion Criteria
- Having had symptoms less than 12 weeks
- Tenderness and pain over lateral epicondylitis
- Provocation of the lateral elbow pain with at least one of the following tests - resisted middle finger extension (Maudley's test), resisted wrist extension or passive stretch of wrist extensors (Mill's test).
Exclusion Criteria
- Cervical spondylosis or radiculopathy
- Diabetes mellitus
- Neuropathy
- Arthritis in the upper extremities
- History of injection and physical therapy for lateral epicondylitis within the last three months
- Pregnancy
- History of surgery or acute trauma in the elbow
- Allergy to tape
Data sourced from ClinicalTrials.gov (NCT03074500). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.